Solid Biosciences Inc. — Director's Dealing 2019

Aug 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-08-12

Reporting Person: Ganot Ilan (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-12	Restricted Stock Units	$	A	1600	Acquired		Common Stock (1600)	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Solid Biosciences Inc. common stock.

F2: The restricted stock units vest in two equal installments on February 12, 2020 and August 12, 2020. Vested shares will be delivered to the reporting person on the applicable vesting date.